Yingpu Sun

No ORCID on file · 11 papers in corpus · active 2012-2025

Study types

  • article 6
  • other 3
  • preprint 1
  • rct 1

Condition tags

  • endometriosis 7
  • infertility 1
  • adenomyosis 1
article 2025
·doi:10.7150/ijbs.98653

Ovarian hyperstimulation syndrome (OHSS) is a severe complication of controlled ovarian hyperstimulation (COH) during in vitro fertilization (IVF) treatment, characterized by increased capillary permeability.Vascular endothelial growth fact…

other 2022
Frontiers in genetics ·doi:10.3389/fgene.2022.998417

Endometriosis (EMs), one of the most common gynecological diseases, seriously affects the health and wellness of women; however, the underlying pathogenesis remains unclear. This study focused on dysregulated genes and their predicted trans…

article 2021
Frontiers in endocrinology ·doi:10.3389/fendo.2021.655803

Background Some studies have demonstrated that adenomyosis patients can achieve a comparable pregnancy outcome with women with normal uteruses, while there is no unanimous conclusion at present. Method We recruited 65 adenomyosis patients a…

article 2020
·doi:10.3389/fendo.2020.00469

Background: Studies have shown that patients with a thin endometrial thickness (EMT 5). In binary logistic regression analysis, age (OR=0.09, P=0.03), number of embryos available(OR=1.71, P=0.00), and uterine condition (OR=6.77, P=0.00 for …

preprint 2020
·doi:10.21203/rs.3.rs-64858/v1

Abstract Persistent supraphysiological serum estradiol (E2) levels during controlled ovarian hyper-stimulation (COH) have a detrimental effect on endometrial receptivity. In this study, we explored RNA expression and DNA methylation profile…

article 2020
·doi:10.1038/s12276-020-0396-y

Ovarian hyperstimulation syndrome (OHSS) is one of the most serious and iatrogenic complications that can occur during in vitro fertilization treatment. Although the pathogenesis of OHSS is not fully understood, vascular endothelial growth …

other 2019
Medical science monitor : international medical journal of experimental and clinical research ·doi:10.12659/MSM.916447

BACKGROUND Patients with endometriosis (EMs) are routinely advised to take GnRH-a for 3-6 months to improve the internal reproductive environment, but this may not be necessary. MATERIAL AND METHODS This retrospective study examined the eff…

article 2019
·doi:10.12659/msm.916447

BACKGROUND: Patients with endometriosis (EMs) are routinely advised to take GnRH-a for 3–6 months to improve the internal reproductive environment, but this may not be necessary. MATERIAL/METHODS: This retrospective study examined the effec…

rct 2018
Reproductive health ·doi:10.1186/s12978-018-0639-8

BACKGROUND: Endometriosis is the major cause of progressive pelvic pain and subfertility. Up to 50% of reproductive-age women suffer from pelvic pain. Endometriosis is a classic indication for IVF. Compared with women whose inability to pro…

other 2014
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-014-0246-8

PURPOSE: To evaluate basal testosterone (T) levels in women undergoing in vitro fertilization (IVF) cycles and examine the association between basal T levels and ovarian response or IVF pregnancy outcome. METHODS: We retrospectively analyz…

article 2012
Contemporary clinical trials ·doi:10.1016/j.cct.2012.07.009